John Daniel
Cofounder, Executive Vice President of Global Partnerships
We are very excited about Arab Health 2024 and looking forward to meeting you!!!
ProgenaCare has developed the first and only Human Keratin advanced wound products. My name is John Daniel, cofounder and EVP. We are interested in distributor partners, hospitals, burn centers and medical clinics. We are currently treating patients on 4 continents. We are a purpose driven and patient focused privately held company. Our goal is to educate, treat patients and reduce human suffering through our innovative medical products and devices.
Atlanta, United States
Healthcare
We are a purpose-driven medical device company leveraging cutting-edge advances in biomaterials to provide effective, affordable advanced wound care solutions to patients across the socioeconomic spectrum and around the world. After more than a decade of research and development, ProgenaCare Global is commercializing ProgenaMatrix®, the first product built on our proprietary human keratin platform. ProgenaMatrix is the only commercially available human keratin matrix for wound care. Due to its unique keratin technology, ProgenaMatrix is capable of providing excellent outcomes for patients with complex wounds in a highly cost-effective manner.
